HOSKINS ERIC enters HELUS PHARMA INC. with 158.63K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Indirect Derivatives
Filed: 10/23/2026ACC: 0000912282-26-001383
158.63K
Baseline shares
1% direct
1.32K
Direct ownership
1 position
30.26K
Derivative underlying
1 instrument
3
Security positions
157.32K indirect
Non-Derivative Holdings3
Common Shares
DirectShares owned1.32K
Common Shares
IndirectShares owned1.32K
Common Shares
IndirectShares owned156K
Total
1.32K direct·157.32K indirect158.63K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Shares | 1.32K | Direct |
| Common Shares | 1.32K | Indirect |
| Common Shares | 156K | Indirect |
| Total | 158.63K | 1.32K direct·157.32K indirect |
Derivative Holdings1
Warrants
IndirectUnderlying security
Common Shares
Underlying shares
30.26K
Shares owned
N/A
Exercise price
6.79
Expiration
—
Exercise window
—
Total
Underlying
30.26K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Warrants Indirect | Common Shares | 6.79 | — | — | 30.26K | N/A |
| Total | 30.26K | 0.00 | ||||